Found: 9
Select item for more details and to access through your institution.
Use of circulating tumor cells in prospective clinical trials for NSCLC patients – standardization of the pre-analytical conditions.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 6, p. 980, doi. 10.1515/cclm-2017-0764
- By:
- Publication type:
- Article
High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 6, p. 1022, doi. 10.1002/cam4.661
- By:
- Publication type:
- Article
Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 751, doi. 10.3390/diagnostics12030751
- By:
- Publication type:
- Article
Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Shifting from Immunohistochemistry to Screen for ALK Rearrangements: Real-World Experience in a Large Single-Center Cohort of Patients with Non-Small-Cell Lung Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 12, p. 2219, doi. 10.3390/cancers16122219
- By:
- Publication type:
- Article
Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France).
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092258
- By:
- Publication type:
- Article
Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France).
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 955, doi. 10.3390/cancers12040955
- By:
- Publication type:
- Article
In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1271, doi. 10.3390/cancers11091271
- By:
- Publication type:
- Article
Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.
- Published in:
- Cancers, 2018, v. 10, n. 4, p. 88, doi. 10.3390/cancers10040088
- By:
- Publication type:
- Article